Dr. McBride’s research focuses on clinical effectiveness and systems-based approaches to patient safety and quality in caring for hospitalized children. Her most recent projects have aimed to develop best clinical practices for children hospitalized with high-risk pediatric conditions such as asthma, bronchiolitis and osteomyelitis. She receives both federal and private funding for her research. Her present work includes a federally funded, multi-centered study aimed at augmenting a national pediatric database (Pediatric Health Information System- PHIS) with real-time clinical data to improve the reliability of future clinical research. She currently leads a comparative effectiveness study using this augmented database to compare treatment failure rates for osteomyelitis in the era of increased community-acquired methicillin-resistant staph aureus (MRSA). In addition, she is part of a leadership team conducting a privately funded national stakeholder project to develop national consensus guidelines for pediatric hospital discharge planning.
About Sarah McBride
Dr. McBride is an Instructor in Pediatrics at Harvard Medical School. She completed her pediatric residency training at The Children’s Hospital of Philadelphia and a Fellowship in Hospital Medicine at Boston Children’s Hospital including the Program for Clinical Effectiveness at Harvard School of Public Health. She is a Director of Resident Education for Inpatient Medicine and attends on the inpatient pediatric wards at Boston Children’s Hospital while supervising Boston Combined Residency Program pediatric residents and Harvard medical students. She is a member of the teaching faculty for other resident curriculum courses. Dr. McBride is also involved in a number of hospital-wide committees related to safety and quality initiatives.
2010-2014 PHIS +: Comparative Effectiveness of Empiric Antibiotic Choices for Treatment of Osteomyelitis in the era of MRSA
Agency for Health Care Research and Quality (AHRQ), R01 HS019862-01
This study uses the augmented Pediatric Health Information System (PHIS) database to compare treatment failure rates among those patients hospitalized with osteomyelitis who are treated empirically with MRSA-covering antibiotics to those patients who do not receive initial antibiotics to cover MRSA.